News Posts List
First Patient Dosed in a Phase I Study of CB-1158
09/16/2016
Arginase is an enzyme in myeloid-derived suppressor cells (MDSCs), which prevents T-cell and natural killer (NK) cell activation in tumors.
FDA Modifies Dosing Regimen for Nivolumab
09/16/2016
The new dosage regimen is for 240mg IV every 2 weeks until disease progression or intolerable toxicity for renal cell carcinoma...
Exelixis, Ipsen say EU approves kidney cancer drug
09/15/2016
The drug, cabometyx, is approved for patients in advanced stages of the disease who have already received prior treatment. The drug was approved by the U.S.'s Food and Drug Administration in April.
Targeted therapy: An elusive cancer target
09/15/2016
Advanced tumors may have met their match with new drugs, but why have these treatments proved ineffective at stopping early-stage tumors from coming back?
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney
09/15/2016
Cell lines (CAKI-1, HK2 or A704) were either transfected with 2 independent siRNAs or non-target controls.
Kidney and Thyroid Cancer Rates Up Among U.S. Children, Study Finds
09/12/2016
Siegel hopes that these findings will encourage investigators to find out the "driving forces behind these increases."
What Is Sickle Cell Trait?
09/11/2016
In rare circumstances, a person with sickle cell trait may develop a rare kidney cancer called renal medullary carcinoma.
Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations
09/11/2016
High BMI is a prognostic factor for improved survival and progression-free survival in patients with metastatic RCC...
VICC helps launch new alliance for rare kidney cancer
08/29/2016
Children, adolescents or young adults, particularly African-Americans, diagnosed with advanced kidney cancer may actually have a rare form of the disease known as renal medullary carcinoma (RMC) that requires a specialized approach and expert intervention.
Hereditary leiomyomatosis and renal cell cancer
08/29/2016
Summary of "Hereditary leiomyomatosis and renal cell cancer syndrome: identification and clinical characterization of a novel mutation in the FH gene in a Colombian family."